Abstract
Fungating breast cancer severely affects patients’ daily lives, and patient management poses major oncology challenges. To present 10-year outcomes of unique tumor presentation, suggesting a focused algorithm for surgical management and providing deep analysis for factors affecting survival and surgical outcomes. Eighty-two patients with fungating breast cancer were enrolled in the period from January 2010 to February 2020 in the Mansoura University Oncology Center database. Epidemiological and pathological characteristics, risk factors, different surgical treatment techniques, and surgical and oncological outcomes were reviewed. Preoperative systemic therapy was used in 41 patients, with the majority (77.8%) showing progressive response. Mastectomy was performed in 81 (98.8%) patients, with primary wound closure in 71 (86.6%), and wide local excision in a single patient (1.2%). Different reconstructive techniques in non-primary closure operations were used. Complications were reported in 33 (40.7%) patients, of which 16 (48.5%) were of Clavien-Dindo grade II category. Loco-regional recurrence occurred in 20.7% of patients. The mortality rate during follow-up was 31.7% (n = 26). Estimated mean overall survival (with 95% CI) was 55.96 (41.98–69.9) months; estimated mean loco-regional recurrence-free survival (with 95% CI) was 38.01 (24.6–51.4) months. Surgery is a cornerstone fungating breast cancer treatment option, but at the expense of high morbidity. Sophisticated reconstructive procedures may be indicated for wound closure. A suggested algorithm based on the center’s experience of wound management in difficult mastectomy cases is displayed.
Similar content being viewed by others
Data Availability
All the clinical, radiological, and pathological data used in this manuscript is available on Mansoura University medical system (Ibn Sina Hospital Management System). http://srv137.mans.edu.eg/mus/newSystem/
References
Forouzanfar MH, Foreman KJ, Delossantos AM et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (London, England) 378(9801):1461–1484
Valero VV, Buzdar AU, Hortobagyi GN (1996) Locally advanced breast cancer. Oncologist 1(1 & 2):8–17
Bogusevicius A, Cepuliene D, Sepetauskiene E (2014) The integrated evaluation of the results of oncoplastic surgery for locally advanced breast cancer. Breast J 20(1):53–60
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England) 365(9472):1687–1717
Siegel RL, Miller KD, Jemal A, Cancer statistics (2015) CA: a Cancer. J Clin 65(1):5–29
Beh SY, Leow LC (2016) Fungating breast cancer and other malignant wounds: epidemiology, assessment and management. Exp Rev Quality Life Cancer Care 1(2):137–144
Coebergh JW, Jansen-Heijnen ML, Louwman WJ, ACV (2001) Cancer incidence and survival in the South of the Netherlands, 1955–1999 and incidence in the North of Belgium, 1996–1998. Eindhoven, the Netherlands: Compr Cancer Centre S (IKZ).
Wieland AW, Louwman MW, Voogd AC, van Beek MW, Vreugdenhil G, Roumen RM (2004) Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b). Breast J Mar-Apr 10(2):123–128
Jarvis V (2014) The range and role of palliative interventions for locally advanced breast cancer. Curr Opin Support Palliat Care 8(1):70–76
Bottomley A, Therasse P, Piccart M et al (2005) Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial. Lancet Oncol 6(5):287–294
Tryfonidis K, Senkus E, Cardoso MJ, Cardoso F (2015) Management of locally advanced breast cancer-perspectives and future directions. Nature Rev. Clin Oncol 12(3):147–162
Chia D, Tan EY, Lu J et al (2016) Clinical outcomes of fungating breast cancer treated with palliative radiotherapy. J Radiat Oncol 5(4):411–416
Seaman S (2006) Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs 22(3):185–193
S T (1992) Current practices in the management of fungating lesions and radiotherapy damaged skin. Bridgend, Mid Glamorgan: The Surgical Materials Testing Laboratory
Probst S, Arber A, Faithfull S (2009) Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland. Eur J Oncol Nurs: Off J Eur Oncol Nurs Soc 13(4):295–298
Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA (2006) The severity, outcome and challenges of breast cancer in Nigeria. Breast (Edinburgh, Scotland) 15(3):399–409
Kumar A, Shah LL, Khanna S, Khanna NN (1987) Preoperative chemotherapy for fungating breast cancer. J Surg Oncol 36(4):295–298
Grocott P, Cowley S (2001) The palliative management of fungating malignant wounds—generalising from multiple-case study data using a system of reasoning. Int J Nurs Stud 38(5):533–545
Heisey R, Clemons M, Granek L et al (2011) Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians. Curr Oncol 18(5):e227–e237
Gao RW, Edlund S, Yuan J (2017) Dramatic regression of a fungating breast lesion treated with radiation therapy. Cureus 9(6):e1360
El Saghir NS, Adebamowo CA, Anderson BO et al (2011) Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative. The Breast 20:S3–S11
Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS (2012) Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ (Clinical research ed) 344:e2718
Lund-Nielsen B, Müller K, Adamsen L (2005) Malignant wounds in women with breast cancer: feminine and sexual perspectives. J Clin Nurs 14(1):56–64
Maida V, Ennis M, Kuziemsky C, Trozzolo L (2009) Symptoms associated with malignant wounds: a prospective case series. J Pain Symptom Manage 37(2):206–211
Alexander S (2009) Malignant fungating wounds: key symptoms and psychosocial issues. J Wound Care 18(8):325–329
Lo SF, Hayter M, Hu WY, Tai CY, Hsu MY, Li YF (2012) Symptom burden and quality of life in patients with malignant fungating wounds. J Adv Nurs 68(6):1312–1321
Probst S, Arber A, Faithfull S (2013) Malignant fungating wounds–2013; the meaning of living in an unbounded body. Eur J Oncol Nurs 17(1):38–45
Grewal AS, Freedman GM, Jones JA, Taunk NK (2019) Hypofractionated radiation therapy for durable palliative treatment of bleeding, fungating breast cancers. Pract Radiat Oncol 9(2):73–76
Gunduz N, Fisher B, Saffer EA (1979) Effect of surgical removal on the growth and kinetics of residual tumor. Can Res 39(10):3861–3865
(NCCN) NCCN. Breast cancer (version 3.2019). 2019.
Vempati P, Knoll MA, Dharmarajan K, Green S, Tiersten A, Bakst RL (2016) Palliation of ulcerative breast lesions with radiation. Anticancer Res 36(9):4701–4705
Petrella F, Radice D, Borri A et al (2016) Chest wall resection and reconstruction for locally recurrent breast cancer: from technical aspects to biological assessment. Surg: J Royal Colleges Surgeons Edinburgh Ireland 14(1):26–32
Pereira J, Phan T (2004) Management of bleeding in patients with advanced cancer. Oncologist 9(5):561–570
Moriarty JM, Xing M, Loh CT (2012) Particle embolization to control life-threatening hemorrhage from a fungating locally advanced breast carcinoma: a case report. J Med Case Rep 6(1):186
Ugras S, Gemignani ML, Connolly PH, Finley DJ (2015) Endovascular approach to acute hemorrhage in locally advanced breast cancer. Breast J 21(2):189–191
Aksoy Ş, Akçe B, Kılıçkesmez Ö et al (2016) Transcatheter arterial embolization for controlling severe bleeding from recurrent locally-advanced breast cancer. J Breast Health 12(3):137–140
Crisera CA, Chang EI, Da Lio AL, Festekjian JH, Mehrara BJ (2011) Immediate free flap reconstruction for advanced-stage breast cancer: is it safe? Plast Reconstr Surg 128(1):32–41
Pathy NB, Verkooijen HM, Taib NA, Hartman M, Yip CH (2011) Impact of breast surgery on survival in women presenting with metastatic breast cancer. Br J Surg 98(11):1566–1572
Sood A, Daniali LN, Rezzadeh KS, Lee ES, Keith J (2015) Management and reconstruction in the breast cancer patient with a fungating T4b tumor. Eplasty 15:e39–e39
Downes KJ, Glatt BS, Kanchwala SK et al (2005) Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer 103(5):906–913
Badwe R, Hawaldar R, Nair N et al (2015) Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol 16(13):1380–1388
Khan SA, Zhao F, Solin LJ et al (2020) A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108). J Clin Oncol 38(18_suppl):LBA2–LBA2
Lo SF, Hu WY, Hayter M, Chang SC, Hsu MY, Wu LY (2008) Experiences of living with a malignant fungating wound: a qualitative study. J Clin Nurs 17(20):2699–2708
Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784–1792
Author information
Authors and Affiliations
Contributions
All authors have read and approved the manuscript. Data collection and revision: AA, AE, KA, KAW, SA, MZ, OH. Conceptualization, writing: AA. Supervision and revision: MA, KAW, IH, MZ, OH. Statistical analysis: IH. Editing: OH.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
All procedures performed in the study involving human participants followed the ethical standards of the institutional research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All the patients signed written consent for the surgical maneuvers for resection and reconstruction. This is a retrospective study. Consent for participation in the study itself is not applicable. Approval was obtained from the Institutional Review Board of the Faculty of Medicine, Mansoura University (MFM-IRB), under code number R.20.10.1040.
Consent for Publication
N/A.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abdallah, A., Abdelwahab, K., Awny, S. et al. Fungating and Ulcerating Breast Cancer: Wound Closure Algorithm, Complications, and Survival Trends. Indian J Surg Oncol 14, 93–105 (2023). https://doi.org/10.1007/s13193-022-01602-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-022-01602-x